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Abstract
The coronavirus M protein, the most abundant coronaviral envelope component, is invariably glycosylated, which provides the virion
with a diffuse, hydrophilic cover on its outer surface. Remarkably, while the group 1 and group 3 coronaviruses all have M proteins with
N-linked sugars, the M proteins of the group 2 coronaviruses [e.g., mouse hepatitis virus (MHV)] are O-glycosylated. The conservation of
the N- and O-glycosylation motifs suggests that each of these types of carbohydrate modifications is beneficial to their respective virus.
Since glycosylation of the M protein is not required for virus assembly, the oligosaccharides are likely to be involved in the virus–host
interaction. In order to investigate the role of the M protein glycosylation in the host, two genetically modified MHVs were generated by
using targeted RNA recombination. The recombinant viruses carried M proteins that were either N-glycosylated or not glycosylated at all,
and these were compared with the parental, O-glycosylated, virus. The M protein glycosylation state did not influence the tissue culture
growth characteristics of the recombinant viruses. However, it affected their interferogenic capacity as measured using fixed, virus-infected
cells. Viruses containing M proteins with N-linked sugars induced type I interferons to higher levels than viruses carrying M proteins with
O-linked sugars. MHV with unglycosylated M proteins appeared to be a poor interferon inducer. In mice, the recombinant viruses differed
in their ability to replicate in the liver, but not in the brain, whereas their in vivo interferogenic capacity did not appear to be affected by
their glycosylation status. Strikingly, their abilities to replicate in the liver correlated with their in vitro interferogenic capacity. This apparent
correlation might be explained by the functioning of lectins, such as the mannose receptor, which are abundantly expressed in the liver but
also play a role in the induction of interferon- by dendritic cells.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Glycosylation is a frequent modification of proteins in
eukaryotic cells. Basically, two types of protein glycosyla-
tion occur. Oligosaccharide side chains are attached to pro-
teins either by N-linkage to asparagine residues or by O-
linkage to hydroxyl groups of serine and threonine residues.
A great variety of functions have been attributed to the
oligosaccharide side chains. Carbohydrates have been
shown to be important for protein folding, structure, and
stability and to be involved in intracellular sorting of pro-
teins (e.g., during quality control) and to play essential roles
in molecular recognition processes (e.g., in the generation of
immune responses) (Drickamer and Taylor, 1998; Helenius
and Aebi, 2001; Rudd and Dwek, 1997; Van den Steen et
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al., 1998). Most viral glycoproteins are structural proteins
that become incorporated into the membrane bilayer of
enveloped viruses. Glycosylation of these envelope proteins
plays an essential role in establishing their bioactive con-
formation and has effects on receptor binding, fusion activ-
ity, and antigenic properties of the virus (Alexander and
Elder, 1984; Braakman and van Anken, 2000; Schulze,
1997).
Coronaviruses, positive-stranded RNA viruses, contain
three to four proteins in their membrane envelope. The
small E protein, a minor component of the virion, is not
glycosylated. The spike (S) glycoprotein and the hemagglu-
tinin-esterase protein—the latter only present in some virus
strains—both carry many N-linked sugar side chains. The S
protein interacts with the coronavirus receptor and mediates
virus–cell and cell–cell fusion. Cotranslational N-glycosyl-
ation is needed for this protein to fold properly and to exit
the endoplasmic reticulum (ER). The S protein was shown
to aggregate when glycosylation was inhibited (Delmas and
Laude, 1990) (our unpublished results), whereas growth of
coronavirus in the presence of the N-glycosylation inhibitor
tunicamycin resulted in the production of spikeless, nonin-
fectious virions, which were devoid of S protein (Holmes et
al., 1981; Rottier et al., 1981; Stern and Sefton, 1982).
The membrane (M) protein is the most abundant enve-
lope component and is almost invariably glycosylated. In-
triguingly, whereas the group 1 and group 3 coronavi-
ruses—with transmissible gastroenteritis virus (TGEV) and
infectious bronchitis virus (IBV) as important representa-
tives, respectively—all contain M proteins with only N-
linked sugars, the M proteins of group 2 coronaviruses such
as mouse hepatitis virus (MHV) are only O-glycosylated
(reviewed by Rottier, 1995). The M protein is a type III
membrane protein. The N- and O-glycosylation motifs are
located within the variable part of the amino-terminal
ectodomain. The O-glycosylation motif consists of a cluster
of hydroxylamino acids and a nearby proline residue, posi-
tioned at the extreme amino terminus of the M protein (de
Haan et al., 1998b).
The M protein plays a central role in coronavirus assem-
bly. Together with the minor E protein it is responsible for
the assembly of the coronavirus envelope (Baudoux et al.,
1998a; Godeke et al., 2000; Vennema et al., 1996). In
addition, the M protein directs the incorporation of the S
protein (Nguyen and Hogue, 1997; Opstelten et al., 1995)
and the nucleocapsid (Narayanan et al., 2000) into the
budding particle. Glycosylation of the M protein is not
required for virus assembly as we demonstrated by using a
viruslike particle (VLP) assembly system (de Haan et al.,
1998a). Furthermore, M protein glycosylation was also
shown not to be critical for interaction with the S protein (de
Haan et al., 1999). These observations are consistent with
studies that used tunicamycin (Rossen et al., 1998; Stern
and Sefton, 1982) and monensin (Niemann et al., 1982) to
inhibit glycosylation in infected cells.
The distinct conservation of N- and O-glycosylation in
the M proteins of the different groups of coronaviruses
suggests that the presence and the particular type of carbo-
hydrates are somehow beneficial to the virus. As glycosyl-
ation is not required for virus assembly, we hypothesized
that the carbohydrates are involved in virus–host interac-
tion. In order to investigate the role of M protein glycosyl-
ation, we generated genetically modified MHVs by using
targeted RNA recombination. The recombinant viruses pre-
pared carried M proteins that were O-glycosylated, N-gly-
cosylated, or not glycosylated at all. Preliminary observa-
tions revealed no differences in the growth properties of the
viruses but suggested that they might differ in their inter-
ferogenic properties (de Haan et al., 2002). This prompted
us to carry out a more in-depth study of the viruses, partic-
ularly with respect to interferon induction in relation to
virulence and to hepatic replication and pathogenesis in
mice. The results surprisingly show that in vitro interferon
induction correlated with replication in and damage to the
liver.
Results
Construction of M protein glycosylation mutants
To examine the role of glycosylation of the ectodomain
of the M protein, mutations expected to either ablate or alter
oligosaccharide addition were directly introduced into the
genome of MHV strain A59 by targeted RNA recombina-
tion (Masters, 1999; Masters et al., 1994). In the first mu-
tant, the functional acceptor site as well as an alternative
acceptor site of O-glycosylation were eliminated by chang-
ing threonine residues 4 and 5 to alanines (de Haan et al.,
1998b). In the second mutant, a consensus N-linked glyco-
sylation site was created in the amino terminus of the M
protein by insertion of two asparagine residues in place of
serine residue 2, in addition to the substitutions of the
threonine residues introduced to make the first mutant.
Thus, the protein expressed from this latter mutant M gene
would be expected to be N-glycosylated only. These muta-
tions were first generated in the transcription vector pFV1
(Fischer et al., 1997) (Fig. 1A) and subsequently were
introduced into MHV through homologous RNA recombi-
nation with the N gene deletion mutant Alb4, which was
counterselected on the basis of its thermolabile phenotype
(Masters, 1999; Masters et al., 1994). Two independent
candidate glycosylation-null mutants, Alb244 and Alb246,
and two independent candidate N-glycosylation mutants,
Alb248 and Alb250, were isolated. The genotypes of these
were confirmed by direct genomic RNA sequencing of the
5 end of the M gene (Fig. 1C) as well as by sequencing of
the region that is deleted in the Alb4 virus genome (not
shown). As isogenic wild-type controls for subsequent ex-
periments we used Alb138 and Alb139, two independent
wild-type recombinants obtained previously from Alb4 us-
ing pFV1-derived donor RNA.
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Fig. 1. Construction of MHV M protein glycosylation mutants. (A) Schematic of transcription vector pFV1 (Fischer et al., 1997), which contains a cDNA copy of
the 5 467 nt of the MHV genome fused to the 3 7406 nt of the MHV genome. The T7 RNA polymerase promoter is denoted by an arrow. The EcoRV and BssHII
sites, used for mutant plasmid construction, and the HindIII site, used for transcription vector truncation, are indicated. The expanded segments of sequence show
the wild-type region encompassing the start of the M gene in pFV1, and, below this, the corresponding sequences of mutant vectors pCM1 to pCM4. Nucleotide
point mutations or insertions are marked by stars, and the resulting changed amino acids are circled. The transcriptional regulatory sequence preceding the M gene
is underlined. (B) Strategy for targeted recombination between recipient virus Alb4 and synthetic donor RNA transcribed from pFV1 or a mutant derivative of pFV1.
The star indicates mutations transduced from the donor RNA into the recombinant genome. (C) Portions of sequence of purified genomic RNA isolated from virions
of recombinants Alb244 and Alb246, which were derived from pCM1 and pCM2, respectively, and Alb248 and Alb250, which were derived from pCM3 and pCM4,
respectively. Sequence was obtained using a primer complementary to nt 113 to 131 of the M protein coding region, and lanes labeled U, C, G, and A were from
reactions terminated with ddATP, ddGTP, ddCTP, and ddTTP, respectively.
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Analysis of viral proteins
To verify whether the viral genomic mutations resulted
in the desired phenotypes, we analyzed the glycosylation
status of the M protein in assembled virions. To this end,
cells infected with the different MHV recombinants were
labeled with 35S-labeled amino acids and the culture media
were collected and processed for immunoprecipitation with
an anti-MHV serum, followed by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) through a
15% polyacrylamide gel. In some cases, tunicamycin was
added during the infection to the culture media to inhibit
N-linked glycosylation. As shown in Fig. 2, when no tuni-
camycin was added, S, N, and M proteins could be precip-
itated from the culture media, indicating that virus particles
had been assembled and released from the cells infected
with the MHV recombinants. The S protein appeared as the
mature 180 kDa glycoprotein (S/gp 180). A fraction of the
S protein had been cleaved into two subunits, both with a
molecular weight of approximately 90 kDa (S/gp90). The M
proteins of the different viruses showed clear differences in
their electrophoretic mobilities. The M proteins obtained
with Alb138 or Alb139 (i.e., the “wild-type” recombinants)
appeared as the typical set of O-glycosylated forms de-
scribed before (Krijnse Locker et al., 1992; Tooze et al.,
1988). The predominant forms are the M protein species
containing galactose and sialic acid (M3 and M4), but the
unglycosylated form (M0; the fastest migrating form) and
the slightly slower migrating form containing only N-acetyl-
galactosamine (M1) were also visible. In contrast, the M
protein released from cells infected with Alb244 or Alb246
migrated in the gel as a single band with approximately the
same electrophoretic mobility as the unglycosylated M pro-
tein species released from Alb138- or Alb139-infected cells.
The M proteins released from cells infected with Alb248 or
Alb250 appeared as a smear in the gel, quite similar to the
M proteins from group I coronaviruses, which carry N-
linked sugars (Rossen et al., 1998; Vennema et al., 1990).
The appearance of the M proteins as a smear in the gel is
probably the result of extensive, heterogeneous modifica-
tions of the sugar side chains. To verify that the M proteins
released from Alb248- and Alb250-infected cells contained
no O-linked sugars in addition to N-linked side chains, we
treated the cells with tunicamycin, which blocks N-linked,
but not O-linked, glycosylation. Since tunicamycin also
affects protein synthesis (Rossen et al., 1998) a longer
exposure of this part of the gel is shown in Fig. 2. After
treatment with tunicamycin the N and M proteins, but not
the S protein, could be precipitated from the culture media.
This is in agreement with experiments, mentioned previ-
ously, which demonstrated that noninfectious virions, de-
void of S protein, are assembled in the presence of tunica-
mycin. Although the glycosylation state of the M proteins
released from cells infected with Alb138 was not affected
by treatment with tunicamycin, confirming that O-glycosyl-
ation was not perturbed, the electrophoretic mobility of the
M proteins released from Alb248- or Alb250-infected cells
was drastically changed by the presence of the drug. These
M proteins now migrated as a single band with the same
electrophoretic mobility as unglycosylated M protein, indi-
cating that in the absence of tunicamycin these M proteins
become N-glycosylated, not O-glycosylated. These results
demonstrated that the recombinant viruses have the pre-
dicted M protein glycosylation phenotypes. Furthermore,
each pair of independently obtained recombinant viruses
behaved identically. Alb138 and Alb139 contain M proteins
with O-linked sugars (ON) and Alb244 and Alb246 carry
M proteins without any attached sugars (ON), whereas
Alb248 and Alb250 contain M proteins with N-linked sug-
ars only (ON).
Tissue culture growth phenotype
After confirmation of the glycosylation phenotypes of
the different viruses, we analyzed their in vitro growth
phenotypes. The recombinant viruses displayed no obvious
differences with respect to plaque size or growth in tissue
culture. Preliminary results indicated that they also exhib-
ited similar one-step growth characteristics in LR7 cells (de
Fig. 2. Analysis of the synthesis of recombinant MHV proteins. LR7 cells
were infected with recombinant viruses as indicated on the top of the gel.
Cells were labeled for 3 h with 35S-labeled amino acids starting 5 h
postinfection. When indicated, tunicamycin (5 g/ml) was added to the
culture media from 2 h postinfection. At the end of the labeling period,
culture media were collected and prepared for immunoprecipitation with
the anti-MHV serum k134 The immunoprecipitates were analyzed by
SDS–15%PAGE. The positions of the different proteins are indicated on
the left.
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Haan et al., 2002). These results were confirmed using
independent recombinants, which showed that all recombi-
nants behaved identically and caused extensive syncytia and
cytopathic effects indistinguishably (data not shown). Pas-
sage 3 stocks of each mutant virus had titers in the range of
1.4 to 2.2  108 PFU/ml, which was similar to the titers
obtained with wild-type recombinant virus. In addition, we
compared the infectivity of the viruses to several other cell
lines, including bone-marrow-derived macrophages, macro-
phage cells lines, dendritic cells derived from the spleen,
and primary hepatocytes. No differences were observed; all
cell types were infected to a similar extent and exhibited
similar cytopathic effects (data not shown). These results
indicate that the glycosylation state of the coronavirus M
protein does not influence the tissue culture growth charac-
teristics.
Induction of type I interferon by formaldehyde-fixed,
coronavirus-infected cells
The induction of type I interferons (IFNs) by most RNA
viruses is initiated by virus-derived double-stranded RNA.
However, several enveloped viruses were shown to stimu-
late interferon- (IFN) expression in peripheral blood
mononuclear (PBM) cells via an alternative pathway in
which virus glycoproteins are involved (Ito, 1994; Milone
and Fitzgerald-Bocarsly, 1998). Also TGEV virions and
TGEV VLPs, as well as fixed, TGEV-infected cells, are
efficient inducers of IFN (Baudoux et al., 1998b). Cell
cultures infected with several other coronaviruses, including
MHV, have also been demonstrated to have interferogenic
capacity (Baudoux et al., 1998a). For TGEV it was demon-
strated that the N-linked sugars on the M protein play an
important role in the induction of IFN (Laude et al., 1992).
The availability of the recombinant MHVs allowed us to
investigate the influence of the M protein glycosylation state
on the interferogenic capacity of these viruses. For this
purpose we infected LMR cells, which are porcine cells
susceptible to MHV due to their constitutive expression of
the MHV receptor (Rossen et al., 1996), with the different
recombinant MHVs. LMR cells were chosen since they can
also be infected with TGEV, which served as a positive
control. LMR monolayers were infected with low (0.1) and
high (10) multiplicity of infection (m.o.i.). After fixation at
9.5 h postinfection the cell monolayers were incubated
overnight with porcine PBM cells. Serial 2-fold dilutions of
the culture media were subsequently assayed for antiviral
activity (i.e., IFN activity) on LMR cells using vesicular
stomatitis virus (VSV) as a challenge virus. The IFN pro-
duced by the porcine PBM cells has been characterized as
type I IFN, as it was neutralized for more than 90% by an
antitype I IFN antiserum (Charley and Laude, 1988; La
Bonnardiere et al., 1986). Fig. 3 shows the results from two
typical experiments. LMR cells infected with Alb248 and
Alb250 (ON) reproducibly induced the highest type I
IFN activity, after infection at both low and high m.o.i. The
interferogenic capacity of these monolayers was almost as
high as that of the cells infected with TGEV, the positive
control. The interferogenic activity of Alb138 and Alb139
(ON) was reproducibly lower (5- to 30-fold) than that of
Alb248 and 250 (ON), whereas Alb244- and Alb246-
(ON) infected cells displayed an even lower interfero-
genic capacity (30- to 200-fold), especially at m.o.i. 0.1.
Each pair of independent recombinant viruses behaved al-
most identically in the IFN assay, further demonstrating the
reproducibility of the assay.
The extent of induction of IFN by TGEV was found to
parallel the level of expression of M antigen by the fixed
cells (Baudoux et al., 1998b). It was therefore necessary to
confirm that the effects we observed were not due simply to
differences in M protein expression levels. Unfortunately,
the amino acid changes in the ectodomain of the M protein
are known to affect the antigenicity of this domain of the M
protein (de Haan et al., 1998b), which would make inter-
pretation of M protein antigen levels exposed by the cells
troublesome. As an alternative control the fixed monolayers,
used to induce IFN synthesis by the PBM cells, were im-
munocytochemically studied for MHV infection. The dif-
ferent recombinant MHVs appeared to have infected the
LMR cells to the same extent (data not shown). Addition-
ally, MHV-infected LMR cells were labeled with 35S-la-
beled amino acids, lysed and processed for immunoprecipi-
tation using the anti-MHV serum that contains antibodies to
domains other than the ectodomain, including the endodo-
main (Rottier et al., 1981, 1990). Prior to gel electrophoresis
the immunoprecipitates were treated with PNGase F.
PNGase F removes N-linked sugars from proteins and fa-
cilitates the quantitation of N-linked proteins, which other-
Fig. 3. Induction of type I interferon by formaldehyde-fixed, coronavirus-
infected cells. LMR cells were infected in duplicate with each recombinant
virus or TGEV at a multiplicity of 0.1 or 10 PFU per cell. At 9.5 h
postinfection cells were fixed with 3% formaldehyde. PBM cells were
induced to produce IFN by overnight incubation at 37°C on the TGEV-
or MHV-infected, fixed cells. Supernatants were collected and serial two-
fold dilutions were assayed for IFN in an infection inhibition assay on
LMR cells using VSV as a challenge virus. For each type of recombinant
the mean value is shown, and the standard deviation is indicated. The IFN
produced by the porcine PBM cells has been characterized as type I IFN,
as it was neutralized by more than 90% by an antitype I IFN-antiserum
(Charley and Laude, 1988; La Bonnardiere et al., 1986).
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wise would appear as a smear in the gel due to the extensive
heterogeneous modifications. Quantitation of the M protein
expression levels, using a phosphorimager, indicated that
the N-glycosylated, O-glycosylated, and unglycosylated M
proteins were all expressed at similar levels (data not
shown). These two controls, together with the knowledge
that neither the ectodomain of the M protein nor its glyco-
sylation is important for M protein intracellular transport
(de Haan et al., 1998a, 1998b; Mayer et al., 1988; Rottier et
al., 1990), led us to conclude that the differences in the
induction of IFN can not be the result of different levels of
M protein exposure at the cell surface. The most likely
explanation for the differences found are the different gly-
cosylation states of the M proteins. Thus, coronaviruses
containing M proteins with N-linked sugars induced type I
IFN to higher levels than viruses carrying O-glycosylated M
proteins. MHVs in which the M proteins are unglycosylated
appeared to be poor IFN inducers.
Virulence of recombinant viruses
MHV-A59 is a dual-tropic virus producing hepatitis and
encephalitis. As a first step to characterize the properties of
the recombinant MHV-A59 viruses in their natural host, we
determined the virulence of the recombinant viruses. Mice
were inoculated intracranially with four 10-fold serial dilu-
tions of Alb138, Alb244, and Alb248. Infected mice were
observed for survival and a 50% lethal dose (LD50) was
calculated for each virus. All recombinant viruses displayed
the same LD50 value of 3.8  103 or virulence. Thus, the M
protein glycosylation state does not appear to influence
MHV-A59 virulence as assayed by intracranial inoculation.
Replication in the brain
Since no difference in virulence was observed after in-
tracranial inoculation, the recombinant viruses were char-
acterized in more detail by analyzing their in vivo replica-
tion. Thus mice were inoculated intracranially with viruses
Alb138, Alb244, and Alb248 at a dose of 1  103 PFU. No
significant differences in viral replication were observed (de
Haan et al., 2002). In view of the artificial nature of intra-
cranial inoculation, the experiment was repeated, but this
time 1.4  105 PFU were inoculated intranasally, the pre-
sumed natural route of infection. Once again, however, the
different recombinant viruses appeared to replicate to the
same extent in the brain (Fig. 4). Apparently, the M protein
glycosylation state is not an important factor for migration
to and replication in the brain of MHV-A59.
Replication in the liver
Finally, we investigated replication of the different vi-
ruses in liver. When mice were inoculated intranasally with
a low dose (1  103 PFU), virus could never be detected in
the brain, but was detected in the liver, in approximately
half of the animals. The recombinant viruses appeared to
replicate in the liver to a different extent, MHV-Alb248
(ON) being able to replicate to the highest titers (data not
shown). These results, however, did not differ significantly
and therefore prompted us to study viral replication in the
liver in a more controllable way by intraperitoneal inocula-
tion. Mice were inoculated with 1  105 PFU, and replica-
tion in the liver was determined at day 4 postinfection. As
Fig. 5A reveals, Alb248 (ON) appeared to replicate to a
much higher extent than Alb138 (ON), which in turn,
replicated slightly better than Alb244 (ON). Statistical
analysis done by Student’s t test revealed the significance of
the differences between the titers (Fig. 5A). Similar results
were obtained with the other, independently generated re-
combinant viruses, which confirms the observed pheno-
types. The results could further be confirmed by immuno-
histochemical analysis of the livers (Fig. 5B). To this end,
liver samples were fixed in phosphate-buffered formalin,
embedded in paraffin, sectioned, and stained with hematox-
ylin. Viral antigen was detected with the polyclonal anti-
MHV serum. A number of small lesions were seen in the
livers of mice infected with Alb138 or Alb244. Lesions
appeared slightly larger and showed larger necrotic centers
after infection with Alb138. In animals infected with
Alb248, hepatocellular degeneration and necrosis were so
extreme that lesions were no longer separated. These re-
sults, reproduced in independent experiments, clearly dem-
onstrated that MHV expressing M proteins with N-linked
sugars replicated to a higher extent in the liver than MHV
carrying O-linked sugars. MHV containing M proteins
without any sugars replicated to the lowest extent.
Sensitivity to IFN in vitro and induction of IFN in the
liver
Strikingly, the different extents to which the viruses
replicated in the liver appeared to correlate with the differ-
ent interferogenic capacities of the fixed, virus-infected cells
Fig. 4. Replication of MHV recombinants in the brain. C57BI/6 mice were
inoculated with the indicated recombinant intranasally at a dose of 1.4 
105 PFU. Mice were sacrificed on days 1, 3, 5, and 7 postinfection and
virus titers in the brains were determined by plaque-assay on L2 cell
monolayers.
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Fig. 5. Replication of MHV recombinants in the liver. C57BI/6 mice were inoculated with the indicated recombinant viruses by injection into the
intraperitoneal cavity. Mice were sacrificed and the livers were removed at day 4 postinfection. (A) Virus titers were determined by plaque-assay on LR7
cell monolayers following homogenization of the organs. P values determined by Student’s t test are indicated. (B) For immunohistochemical analysis, the
liver samples were fixed in phosphate-buffered formalin, embedded in paraffin, sectioned and stained with hematoxylin. Viral antigen was detected with the
anti-MHV serum k134, using peroxidase conjugated swine immunoglobulins to rabbit immunoglobulins as secondary antibodies. Peroxidase was visualized
using diaminobenzidine. Magnification: 25 (left side) and 50 (right side).
(compare Fig. 3 with Fig. 5A). To study this apparent
correlation in more detail, the induction of IFN in vivo was
analyzed. Using a IFN bioassay, we were not able to detect
differences in IFN levels in mouse sera early after infection
with the MHV recombinants (data not shown). Also, when
we measured the IFN levels in livers of mice that had been
infected with recombinant viruses carrying N-glycosylated
or unglycosylated M proteins using a mouse IFN-specific
ELISA, very similar IFN levels were observed both at day
1 and at day 3 postinfection (Fig. 6). Apparently, although
the glycosylation status of the coronavirus M protein mod-
ulates the interferogenic capacity of the viruses in the in
vitro assay, the induction of IFN in vivo does not appear
to be affected. Finally, we analyzed whether the differences
in viral replication in the liver might be explained by dif-
ferent sensitivities of the recombinant viruses to IFN.
Therefore, the antiviral activity of IFN against the three
types of viruses was analyzed on LR7 cells, taking VSV
along as a control. The recombinant viruses displayed a
similar sensitivity to IFN (data not shown), that was much
less than that observed for VSV and that cannot explain the
differences in viral replication in the liver.
Discussion
The coronaviral membrane basically consists of a dense
matrix of laterally interacting M proteins, in which the
other, much less abundant, envelope proteins are incorpo-
rated (de Haan et al., 2000). The oligosaccharides exposed
on the coronavirus M protein thus constitute a diffuse,
hydrophilic cover on the outer surface of the virion. Oligo-
saccharide types and their attachment sites on polypeptides
are ultimately defined by the viral genome. Due to the lack
of editing functions in the RNA-dependent RNA polymer-
ase, replication of the coronaviral genome is prone to mu-
tation at a high frequency. Nevertheless, a remarkably well-
conserved dichotomy exists among coronaviruses with
respect to the type of M protein glycosylation, which
prompted us to search for the presumed function of these
sugars. To this end, we used targeted recombination to
generate mutant MHVs carrying M proteins that were O-
glycosylated, N-glycosylated, or not glycosylated at all.
Although no differences were observed between these re-
combinant viruses when grown in cell culture, in mice
glycosylation appeared to influence the ability of the recom-
binant viruses to replicate in the liver but not in the brain.
The glycosylation state of the recombinant viruses also
affected the interferogenic capacity of fixed, virus-infected
cells in a way that correlated with the extent of viral repli-
cation in the liver and, hence, with the degree of hepatic
pathology. However, when the interferogenic capacity of
the recombinant viruses in the liver was determined, no
differences were observed.
Glycosylation of the coronavirus M protein is not impor-
tant for virus assembly or replication per se. The M protein
glycosylation state did not influence the tissue culture
growth characteristics of the recombinant viruses in several
cell types, nor did it affect replication in the mouse brain (de
Haan et al., 2002; this study). These results confirm and
extend previous studies, using either glycosylation inhibi-
tors or a viruslike particle assembly system, which demon-
strated that glycosylation of the M protein does not play an
appreciable role in virion assembly (de Haan et al., 1998a).
In addition, both for MHV (strain RI) and TGEV, mutants
have been described that contain unglycosylated M pro-
teins. Their M proteins have disrupted O- or N-glycosyla-
tion motifs, respectively. The TGEV mutant was demon-
strated to replicate efficiently in vitro (Laude et al., 1992),
whereas MHV-RI appeared to differ from other MHV
strains in its inability to use an isoform of the MHV receptor
(mmCGM2 or CEACAM1b) (Compton, 1994). Since the
recombinant viruses generated in this study were able to use
this MHV receptor isoform to infect the same cells (data not
shown), the result obtained with MHV-RI is not due to the
lack of O-linked sugars on its M protein but can probably be
attributed to mutations in its S protein. Recently, MHV-2
was demonstrated to carry both N-linked and O-linked sug-
ars at its M protein, indicating that both types of glycosyl-
ation can occur side by side on the same M protein (Yamada
et al., 2000), as we had observed as well (de Haan et al.,
1998a).
Glycosylation of the coronavirus M protein is a strongly
conserved feature. As a consequence, we expected an im-
portant role for the carbohydrates during coronavirus infec-
tion of the natural host, even though glycosylation of the M
protein was not required for efficient growth in vitro. In-
deed, the recombinant viruses differed in their ability to
replicate in the liver and to induce hepatitis, although they
replicated to the same extent in the brain. Apparently, the
difference in their hepatitis inducing abilities does not result
from the recombinant viruses having different replication
kinetics. Previously, Navas et al. (2001) demonstrated that
the extent of replication and the degree of hepatitis in the
Fig. 6. Induction of IFN in liver. C57BI/6 mice were inoculated with the
indicated recombinant viruses by injection into the intraperitoneal cavity.
Mice were sacrificed and the livers were removed at day 1 and 3 postin-
fection. IFN levels were determined using a mouse IFN ELISA kit and
standard deviations are indicated.
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liver induced by different MHV strains were determined
largely by the S protein. Since the S protein is the viral
attachment protein and mediates virus–cell fusion this is not
surprising. However, we now show that, in addition to the S
protein, mutations in the M protein that alter the glycosyl-
ation state of the protein affect, in a still unknown way, the
outcome of infection in the liver. The strong hepatotropism
of MHV-2, although mainly determined by the S protein,
may therefore be supported by the attachment of sugars to
the M protein both via O- and N-linkages (Navas et al.,
2001; Yamada et al., 2000).
Type I IFNs are an important component of the first line
of defense against virus infections. They are produced by
cells in response to stimulation with several agents, includ-
ing viruses, bacteria, and synthetic nucleic acids. The in-
duction of type I interferons (IFNs) by most RNA viruses is
initiated by virus-derived double-stranded RNA. In addi-
tion, many enveloped viruses are able to stimulate, via their
glycoproteins, type I IFN production by dendritic cells
(Fitzgerald-Bocarsly, 1993; Ito, 1994; Milone and Fitzger-
ald-Bocarsly, 1998; Siegal et al., 1999). We now demon-
strate for MHV that the glycosylation state of the M protein
plays an important role in the induction of type I IFNs in
vitro. MHVs in which the M proteins were unglycosylated
appeared to be poor IFN inducers compared to MHVs
containing glycosylated M proteins. Attachment of oligo-
saccharide side chains to the M protein via N-linkage re-
sulted in a higher interferogenic capacity than when at-
tached via O-linkage. These results confirm and extend
previous studies that demonstrated that several coronavi-
ruses, including MHV, BCoV and TGEV, were able to
induce IFN by their glycoproteins (Baudoux et al., 1998a,
1998b). For TGEV, the oligosaccharides N-linked to the M
protein were demonstrated to be important for efficient
IFN induction. Mutations in the M protein ectodomain that
impaired N-glycosylation decreased the interferogenic ac-
tivity (Laude et al., 1992), whereas antibodies directed to
the TGEV M ectodomain blocked IFN induction (Charley
and Laude, 1988). The TGEV M protein by itself is not able
to induce IFN (Baudoux et al., 1998a, 1998b). It needs to be
coexpressed with its assembly partner E, which suggests
that the induction of IFN is dependent on a specific,
probably regularly organized structure of the M protein.
Strikingly, the extent of viral replication in the liver of
the different recombinant viruses appeared to correlate with
the different interferogenic capacities of the viruses in vitro.
These observations seem paradoxical since type I IFNs play
an important role in the host defence against viral infections
(Muller et al., 1994), whereas several other studies have
demonstrated the protective effect of type I IFNs on MHV
infection in mice (Aurisicchio et al., 2000; Matsuyama et
al., 2000; Smith et al., 1987; Uetsuka et al., 1996). We
observed no differences in the sensitivities of our recombi-
nant viruses to IFN when analyzed in vitro. Furthermore,
we also detected no differences in IFN levels in mouse sera
and in liver after inoculation of mice with the different
MHV recombinants. Apparently, the different interfero-
genic capacities of fixed, virus-infected cells in vitro do not
necessarily reflect the interferogenic capacities of the repli-
cating viruses in vivo. The different abilities of the recom-
binant viruses to replicate in the liver are difficult to explain.
We speculate that they might correlate with differences in
the binding of the viruses to hepatic lectins and, conse-
quently, with their hepatic targeting efficiencies. The induc-
tion and production of IFN in peripheral blood dendritic
cells by several enveloped viruses is mediated by the man-
nose receptor (Milone and Fitzgerald-Bocarsly, 1998). This
receptor is a so-called pattern-recognition receptor (Stahl
and Ezekowitz, 1998), which has been implicated in the
nonspecific recognition of enveloped viruses as well as of
other pathogens (Milone and Fitzgerald-Bocarsly, 1998;
Stahl and Ezekowitz, 1998). The mannose receptor is also
expressed on liver sinusoidal endothelium, where it is an
essential regulator of serum glycoprotein homeostasis (Lee
et al., 2002). By recognizing their carbohydrates—supposed
to function as tags—the receptor appears to target serum
glycoproteins for degradation in the liver. Consequently, it
is conceivable that the differential recognition of the differ-
ently glycosylated MHV recombinants by hepatic lectins
such as the mannose receptor modulates the extent of viral
replication in the liver in proportion to the in vitro inter-
ferogenic capacities of the viruses.
Materials and methods
Cells, viruses, and antibodies
The MHV-A59 mutants Alb138, Alb139, Alb244,
Alb246, Alb248, and Alb250 were propagated in mouse 17
clone 1 cells, and plaque assays and purification were car-
ried out using mouse L2 cells. The viruses were radiola-
beled and analyzed for their one-step growth kinetics in
LR7 cells (Kuo et al., 2000). For the IFN induction and
bioassay LLC-PK1 cells stably expressing the MHV recep-
tor gene (LMR cells; Rossen et al., 1996) were used. PBM
cells were obtained from heparinized blood by Ficoll den-
sity centrifugation as described before (Charley and Laude,
1988). The VSV strain San Juan was used as a challenge
virus in the IFN bioassay. The rabbit polyclonal MHV
strain A59 antiserum k134 has been described earlier (Rot-
tier et al., 1981).
Plasmid constructs
Transcription vectors for the production of donor RNA
for targeted recombination were constructed from the plas-
mid pFV1 (Fischer et al., 1997), which encodes a runoff
transcript consisting of the 5 end of the MHV genome
fused to the start of the S gene and running to the 3 end of
the genome (Fig. 1A). An M gene mutant of pFV1, encod-
ing the substitutions T4A and T5A, was made by transfer of
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the mutations from the previously described plasmid
pTUG3-M-A4A5 (de Haan et al., 1998a). A polymerase
chain reaction (PCR) product was obtained from pTUG3-
M-A4A5 with primer PM303 (5ATCTAATCCAAACAT-
TATGAGTAGT3), which produces half of the EcoRV site
immediately upstream of the M coding region, and primer
LK10 (5CAACAATGCGGTGTCCGCGCCAC3), which
is complementary to the 3 end of the M coding region. The
PCR product was restricted with BssHII and ligated in place
of the EcoRV–BssHII fragment of pFV1 to produce plas-
mids pCM1 and pCM2. An M gene mutant of pFV1 des-
ignated M-N2N3, encoding an M protein in which Ser2 was
replaced by two Asn residues in addition to the substitutions
T4A and T5A, was generated by PCR using primer 932
(5CAAACATTATGAACAACAGTGCTGCTCAGG3),
which directs the desired mutations, and primer 509
(5GTCTAACATACACGGTACCTTTC3), correspond-
ing to a unique KpnI site in the M gene, and cloned into
pTUG3 in a similar way as described for M gene mutant
M-A4A5 (de Haan et al., 1998a). The mutations were
transferred from pTUG3-M-N2N3 into pFV1 via a PCR
product obtained with primers PM304 (5ATCTAATC-
CAAACATTATGAACAACAGT3) and LK10. The PCR
product was restricted with BssHII and ligated in place of
the EcoRV–BssHII fragment of pFV1 to produce plasmids
pCM3 and pCM4. The sequences of all ligation junctions
and all PCR-generated segments were confirmed by DNA
sequencing.
Construction of MHV mutants
Incorporation of mutations into the MHV genome by
targeted RNA recombination was carried out as described
previously (Masters, 1999; Masters et al., 1994). Donor
RNAs transcribed in vitro from HindIII-linearized, pFV1-
derived plasmids were transfected by electroporation into
mouse L2 cells that had been infected with the thermolabile
N gene deletion mutant Alb4. The cells were then plated
onto a monolayer of mouse 17Cl1 cells. Progeny recombi-
nants that had repaired the N gene deletion were selected as
viruses able to form large plaques at the nonpermissive
temperature for Alb4 (39°C). Candidates were plaque puri-
fied and screened for the presence of the cotransduced
mutations in the M gene by reverse transcription–poly-
merase chain reaction (RT–PCR), on the basis of the loss of
a ScaI site that occurs in codons 3 and 4 of the wild-type M
gene (Fig. 1A). Mutant construction was finally confirmed
by direct RNA sequencing of purified genomic RNA (Peng
et al., 1995).
Metabolic labeling and immunoprecipitation
LR7 cells and LMR cells were grown and infected with
each virus at a m.o.i. of 10 PFU/cell. When indicated,
tunicamycin (5 g/ml) was added to the culture media from
2 h postinfection. Before being labeled, cells were starved
for 30 min in cysteine- and methionine-free minimal essen-
tial medium containing 10 mM Hepes (pH 7.2) and 5%
dialyzed fetal bovine serum (FBS). The medium was then
replaced by 600 l of the same medium containing 100 Ci
in vitro cell-labeling mix (Amersham). Cells were labeled
from 5 to 8 h postinfection. At the end of the labeling
period, culture media were collected, cleared by low-speed
centrifugation, and prepared for immunoprecipitation by the
addition of 1:4 volume of 5 times concentrated lysis buffer
(de Haan et al., 1998a). Proteins were immunoprecipitated
from cell lysates as described before (de Haan et al., 1998a).
An amount of 2.5 l of anti-MHV serum k134 was used per
immunoprecipitation. Immune complexes were adsorbed to
Pansorbin cells (Calbiochem) for 30 min at 4°C and were
subsequently collected by centrifugation. Pellets were
washed 4 times by resuspension and centrifugation using
wash buffers as described previously (de Haan et al.,
1998a). The final pellets were suspended in electrophoresis
sample buffer. The immunoprecipitates were analyzed by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE) in 15% polyacrylamide gels.
IFN induction and bioassay
LMR cells grown in 16-mm dishes were infected with
each virus at a m.o.i. of 0.1 or 10 PFU/cell. At 9.5 h
postinfection cells were washed with PBS 3 times and then
fixed overnight with 3% formaldehyde at 4°C. Cells were
then washed three times with PBS–50 mM glycine and
stored in the same buffer. PBM cells were induced to pro-
duce IFN by overnight incubation at 37°C on the TGEV-
or MHV-infected, fixed cells (3  106 PBM cells/well).
Supernatants were collected and serial twofold dilutions
were assayed for IFN in an infection inhibition assay on
LMR cells using VSV as a challenge virus (Laude et al.,
1992). To determine which fraction of the inhibitory effect
was contributed by type I IFN, the bioactivity was also
assayed after neutralization with a sheep antihuman type I
IFN antiserum (La Bonnardiere et al., 1986), which was
kindly provided by B. Charley (INRA). The serum was used
at a final dilution of 1:100 as described before (Charley and
Laude, 1988).
Virulence assay
An LD50 assay was carried out by inoculating 4-week-
old, MHV-negative, C57BI/6 mice intracranially with four
10-fold serial dilutions (5  105–5  102) of recombinant
viruses. Mice were anesthetized with Isoflurane (IsoFlo;
Abbott Laboratories, North Chicago, IL). Viruses were di-
luted using PBS containing 0.75% bovine serum albumin. A
volume of 25 l was used for injection into the left cerebral
hemisphere. Five animals were analyzed for each dose of
virus. LD50 values were calculated by the Reed–Muench
method based on death by 21 days postinfection (Reed and
Muench, 1938).
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Viral replication in brain and liver
Four-week-old C57BI/6 mice were inoculated intracra-
nially (as described above) or intranasally. Five animals per
dose of virus were analyzed. Mice were sacrificed on days
1, 3, 5, and 7 postinfection and perfused with 10 ml PBS,
and the brains and liver were removed. All organs were
weighed and then frozen at 80°C until they were titered
for virus. Virus titers were determined by plaque-assay on
L2 cell monolayers following homogenization of the organs
(Hingley et al., 1994). For analysis of viral replication in the
liver, 8-week-old C57BI/6 mice were inoculated by injec-
tion of 100-l virus dilution into the intraperitoneal cavity.
Mice were sacrificed and the livers were removed at day 4
postinfection. Livers were placed in 1.5 ml DMEM,
weighed, and then frozen at 80°C until titered for virus.
Virus titers were determined by plaque assay on LR7 cell
monolayers following homogenization of the organs. For
immunohistochemical analysis, the liver samples were fixed
in phosphate-buffered formalin, embedded in paraffin, sec-
tioned, and stained with hematoxylin. Viral antigen was
detected with k134 at a 1:400 dilution. Peroxidase-conju-
gated swine immunoglobulins to rabbit immunoglobulins
(Dakopatts) were used as secondary antibodies at a 1:100
dilution. Peroxidase was visualized using diaminobenzi-
dine.
IFN induction in liver
Eight-week-old C57BI/6 mice were inoculated by injec-
tion of 100 l of virus dilution (1.0  105 PFU) into the
intraperitoneal cavity. Mice were sacrificed and the livers
were removed at days 1 and 3 postinfection. Livers were
placed in 1.5 ml DMEM, weighed, and then stored frozen at
80°C until use. Following homogenization of the organs,
IFN levels were determined using a mouse IFN ELISA
kit according to the manufacturer’s instructions (PBL).
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